The Food and Drug Administration has stepped into a simmering debate in California as to whether coffee should come with a cancer warning label.
In March, a judge sided with a nonprofit organization called the Council for Education and Research on Toxics that argued that coffee contains high levels of acrylamide, a cancer-causing chemical compound produced as beans roast.
Coffee companies didn’t deny acrylamide’s presence but argued that it was found at low levels that posed no significant health risk and was outweighed by other health benefits. That argument wasn’t compelling to Los Angeles County Superior Court Judge Elihu Berle.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
